Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.82M P/E - EPS this Y 52.50% Ern Qtrly Grth -
Income -3.63M Forward P/E - EPS next Y -25.00% 50D Avg Chg 2.00%
Sales 72.1k PEG - EPS past 5Y - 200D Avg Chg -18.00%
Dividend N/A Price/Book 0.72 EPS next 5Y - 52W High Chg -82.00%
Recommedations 2.00 Quick Ratio 9.88 Shares Outstanding 2.84M 52W Low Chg 1,171.00%
Insider Own 6.35% ROA -24.86% Shares Float 2.54M Beta 1.34
Inst Own 5.65% ROE -43.97% Shares Shorted/Prior 115.03K/50.72K Price 2.16
Gross Margin 91.90% Profit Margin - Avg. Volume 147,167 Target Price 10.00
Oper. Margin -5,347.41% Earnings Date - Volume 325,213 Change 0.93%
About Silo Pharma, Inc.

Silo Pharma. Inc., a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief. The company's preclinical products include SPC-14 to treat Alzheimer's disease; and SPU-16, a central nervous system homing peptide targeting the central nervous system with indication in multiple sclerosis. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin and ketamine, as well as depression, mental health issues, and neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Silo Pharma, Inc. News
04/23/24 Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
04/10/24 Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
03/20/24 Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
03/18/24 Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
02/28/24 Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
02/14/24 Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
02/01/24 Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
01/24/24 Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
01/04/24 Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
12/28/23 Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
11/21/23 Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD
11/08/23 Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
10/16/23 Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
10/11/23 Silo Pharma Initiates Human Factor Study of SPC-15 for the Treatment of PTSD
09/20/23 Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA
09/12/23 Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD
08/10/23 Silo Pharma Engages Clarivate for Intellectual Property and Patent Management
08/08/23 Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders
06/23/23 Psychedelics Company Silo Pharma Working On Time-Release And Dosage Ketamine Implant And Topical, Hoping To Deliver Steady Pain Relief For Four Million Fibromyalgia Sufferers
06/21/23 Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. Patent
SILO Chatroom

User Image Finanz Posted - 04/23/24

$SILO https://ir.silopharma.com/single-news-releases/?webmasterId=104586&qmodStoryID=6574484726827668

User Image Impiccini Posted - 04/23/24

$SILO 11,705 shares down here at the bottom for the runnup tomorrow premarket… looking for a solid 30%

User Image MS_Tammy Posted - 04/23/24

$SILO they have shorted 75000 shares today.. prime candidate for a swing .,

User Image zx_l Posted - 04/23/24

$SILO this a scam stock? 3 employees??

User Image sa1989 Posted - 04/23/24

$SILO @ZackMorris @Paraboljoker @StockAuthority The entire float is shorted. This ticket is down 10% on a positive news.

User Image VrtcIl Posted - 04/23/24

Float Rotation Elevated squeeze potential on $SILO caused by the float rotation of 2. Hyped on this one. But do not jump in blindly. Calculate the reward to risk ratio always before you enter! Gain: 15.1% Float: 2.5M Short Float: 2.4 %

User Image Impiccini Posted - 04/23/24

$SILO reversal time 👍🏻

User Image exceen49 Posted - 04/23/24

$SILO We need some of the nose spray!!!

User Image GoonKing Posted - 04/23/24

$SILO out. Glad I had oprt to cover this junk lol

User Image zx_l Posted - 04/23/24

$SILO whole stock market is scam!…wake up. Starts with shorting ends with ai…retail is the prey.

User Image sa1989 Posted - 04/23/24

$SILO This is scam with retail traders.

User Image MicroCapsTrader Posted - 04/23/24

$SILO This one is crazy! Maybe company should try releasing some negative PRs to see if we will have a reverse effect on SP vs a good PR! Lol

User Image MaVwapMacd Posted - 04/23/24

$SILO was doing much better before the pr as well…

User Image RallyRaider Posted - 04/23/24

$SILO was like 2.70 in PM!

User Image Acxel305 Posted - 04/23/24

$SILO uuuf with good news ?

User Image MasterOfMyDomains Posted - 04/23/24

$SILO R.I.P.

User Image MasterOfMyDomains Posted - 04/23/24

$SBFM EVERYTHING IS FUCKED. Look at $SILO. Great news and down it goes. Wall Street crooks need to jump off buildings like in Russia.

User Image Liveforonce Posted - 04/23/24

$IBRX $RIOT $LYT and $SILO times time to fly!!!

User Image vmslbdibIumzgzjoch Posted - 04/23/24

$MLEC $SILO gonna rip at bell

User Image ClassifiedTrades Posted - 04/23/24

$SMFL haa what float :) Room to 12.5+ ? $PALI $SILO

User Image vmslbdibIumzgzjoch Posted - 04/23/24

$MLEC meanwhile $SILO creepin back up

User Image Liveforonce Posted - 04/23/24

$EDBL $NKGN $SILO $SMFL

User Image Liveforonce Posted - 04/23/24

$HWH $SILO $SMFL $ZCMD

User Image Liveforonce Posted - 04/23/24

$AGBA $IBRX $SILO $SOUN $ZCMD

User Image Liveforonce Posted - 04/23/24

$SILO

User Image VrtcIl Posted - 04/23/24

Float Rotation Looking at $SILO as it just made a new shares rotation (count: 1). For new entries wait for pullbacks to the moving averages. Would not enter on new highs. Gain: 15.1% Float: 2.5M Short Float: 2.4 %

User Image golferguy62 Posted - 04/23/24

$SILO could we see a run at open?

User Image MaVwapMacd Posted - 04/23/24

$SILO good job shorts

User Image MaVwapMacd Posted - 04/23/24

$SILO back in at $2.09

User Image Liveforonce Posted - 04/23/24

$KSCP $KULR $PALI $SILO $VNRX

Analyst Ratings
Laidlaw & Co. Buy Aug 28, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Weisblum Eric CEO and President CEO and President Dec 14 Buy 1.51 1,100 1,661 169,224 12/18/23
Weisblum Eric CEO and President CEO and President Dec 05 Buy 1.36 1,000 1,360 168,124 12/07/23
Weisblum Eric CEO and President CEO and President Nov 29 Buy 1.55 2,000 3,100 167,124 11/30/23
Weisblum Eric CEO and President CEO and President Nov 22 Buy 1.73 650 1,124 165,124 11/27/23
Weisblum Eric CEO and President CEO and President Nov 16 Buy 1.44 2,900 4,176 160,124 11/20/23
Weisblum Eric CEO and President CEO and President Dec 19 Buy 2.7 330 891 154,854 12/20/22
Weisblum Eric CEO, CFO and Preside.. CEO, CFO and President Jun 17 Buy 0.1147 13,080 1,500 7,724,643 06/21/22